No More Research on Chimpanzees, CBCD Applauds GlaxoSmithKline Decision

Share Article

The Center for the Biology of Chronic Disease (CBCD) applauds GlaxoSmithKline decision to stop using Chimpanzees in antiviral research.

The CBCD commends GlaxoSmithKline, a major pharmaceutical company, for its animal friendly decision.

According to virologist Stanley Lemon of the University of North Carolina: “The chimpanzee model has been very valuable in leading up to where we are now with drug development, but it’s not necessarily on the critical path to discovery now. The need for chimpanzees in antiviral drug development is much less than it was five years ago. You could argue that it’s not there any more.”

The CBCD believes that now, since new methods are available, more pharmaceutical and biotechnology companies should follow the GlaxoSmithKline lead and also implement animal friendly policies.

In addition, the CBCD is happy to mark biotechnology companies that already develop treatments and remedies through animal friendly methods, specifically methods that do not include animal testing.

One such company is polyDNA, which developed Gene-Eden-Blue, a natural remedy that boosts the immune system against the latent hepatitis C virus (Hep c, HCV) and hepatitis B virus (Hep b, HBV), without using any animals in its research.

Instead of using animals, polyDNA developed Gene-Eden-Blue using a proprietary computer program that analyzes the text in scientific papers. To identify safe and effective ingredients, the scientists at polyDNA used the program to analyze thousands of scientific and medical papers published in numerous medical and scientific journals. The result was list of six ingredients that boost the immune system against the latent hepatitis C virus (Hep c, HCV) and hepatitis B virus (Hep b, HBV). These ingredients include selenium, phylanthus amarus, curcumin, quercetin, cinnamon, and licorice, each at a uniquely selected dose. Many of the studies used in the development of Gene-Eden-Blue can be found on Pubmed.gov, the database of references and abstracts on life sciences and biomedical topics compiled by the United States National Library of Medicine (NLM).

“The key to your health is to reduce the level of the chronic viruses in your body to harmless levels. There are no known medications or supplements that can completely eradicate these viruses, except in rare cases where your immune system recovers.” – Dr. Hanan Polansky

So far, the clinical feedback from the users of Gene-Eden-Blue confirms the value of the computer based development process.

To learn more about the latent Hepatitis C virus and how Gene-Eden-Blue can help boost the immune system against it, or to learn more about how Gene-Eden-Blue was developed without the use of animal testing, or to schedule an interview with a polyDNA scientist, please visit http://www.hepatitis-remedy.com or call 585-250-9999.

The Center for the Biology of Chronic Disease (CBCD, http://www.cbcd.net) is a research center recognized by the IRS as a 501(c)(3) non-for-profit organization. The mission of the CBCD is to advance the research on the biology of chronic diseases, and to accelerate the discovery of treatments for these diseases.

The CBCD published the “Purple” book by Dr. Hanan Polansky. The book presents Dr. Polansky’s highly acclaimed scientific theory on the relationship between the DNA of latent (chronic) viruses and the onset of chronic diseases. Dr. Polansky’s book is available as a free download from the CBCD website.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

John S. Boyd, PhD
CENTER FOR THE BIOLOGY OF CHRONIC DISEASE
(585) 250-9999
Email >
Visit website